Articles

MRBK stock results show that Meridian met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More

Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher. More

FMX stock results show that Fomento Economico beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More

While AMC Entertainment may be negotiating its debt payments, AMC stock still faces the broader box office conundrum. More

These electric vehicle stocks are already showing signs that bankruptcy may be around the corner, consider getting them off your portfolio. More

The global robotics market is anticipated to reach more than $286 billion by 2032. That makes the case to buy the best robotics stocks. More

Here's the news that's taking a number of Chinese EV stocks higher today, in a break from a longer-term downtrend in this sector. More

Subscriber Sign in